MYC is overexpressed in over 40% of breast cancer patients and Myc gene amplification (increase in the number of Myc gene) is seen in about 15% of patients. Studies have confirmed the correlation between Myc amplification and poor prognosis. Worldwide, breast cancer is the most commonly-diagnosed type of cancer in women. In 2012, there were 1.6 million new cases and 500,000 deaths were reported, making it also the leading cause of cancer death.
Mihi quidem Antiochum, quem audis, satis belle videris attendere. Hanc igitur quoque transfer in animum dirigentes.
Tamen a proposito, inquam, aberramus. Non igitur potestis voluptate omnia dirigentes aut tueri aut retinere virtutem.